Baxter International Inc.

Baxter Healthcare Sa

Michael V Gallo

Larry Richard Brown

Kimberly A Gillis

The present disclosure is related to microparticle compositions, in which the microparticles are made of nucleic acids and non-polymeric cations, which are suitable for administration to moist or aqueous target locations (e.g., the lung tissue), where the substantially spherical nucleic acid microparticles release the nucleic acids through dissolution, allowing the released nucleic acids to freely interact with the target cells.

Growing community of inventors

Arlington, MA, United States of America

Michael V Gallo